Loading clinical trials...
Loading clinical trials...
A Phase 1b/2a Multicenter Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors
Conditions
Interventions
NOX66
NOX66
+4 more
Locations
2
United States
Beverly Hills Cancer Center
Beverly Hills, California, United States
The University of Texas - MD Anderson Cancer Center - Genitourinary (GU) Cancer Center
Houston, Texas, United States
Start Date
October 25, 2021
Primary Completion Date
May 10, 2023
Completion Date
June 7, 2023
Last Updated
June 18, 2024
Lead Sponsor
Noxopharm Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions